ImmunityBio, Inc. IBRX Impairment of long-lived assets
Impairment of long-lived assets at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:TangibleAssetImpairmentCharges.
The official record: ImmunityBio, Inc.’s 10-K, filed February 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s impairment of long-lived assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s impairment of long-lived assets?
- ImmunityBio, Inc. (IBRX) reported impairment of long-lived assets of $3.5M in Q4 2025.
- What does impairment of long-lived assets mean?
- Specific non-cash charges related to the write-down of physical, long-lived assets such as property, plant, and equipment. This occurs when the expected future cash flows from these assets are insufficient to cover their carrying amount. It highlights the physical capital efficiency of the company's manufacturing or laboratory infrastructure.